US Stock MarketDetailed Quotes

LYRA Lyra Therapeutics

Watchlist
  • 0.139
  • -0.014-9.04%
Close Mar 28 16:00 ET
  • 0.140
  • +0.001+0.79%
Post 20:01 ET
9.15MMarket Cap-0.10P/E (TTM)

Lyra Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.59%-70.01M
40.43%-11.35M
-14.94%-16.22M
-39.90%-19.98M
-41.67%-22.46M
-45.91%-63.3M
-56.68%-19.06M
-30.13%-14.11M
-68.62%-14.28M
-33.14%-15.85M
Net income from continuing operations
-49.07%-93.44M
27.56%-10.98M
24.14%-11.87M
-208.18%-48.13M
-38.12%-22.45M
-13.39%-62.68M
-6.47%-15.16M
-5.99%-15.65M
-8.72%-15.62M
-36.47%-16.26M
Depreciation and amortization
69.42%471K
77.65%151K
157.35%39K
730.43%145K
-52.11%136K
-73.95%278K
-61.71%85K
-124.37%-68K
-108.04%-23K
1.43%284K
Change In working capital
-29.91%-6.35M
49.87%-2.2M
-549.10%-5.48M
380.65%2.7M
-79.29%-1.37M
-207.24%-4.89M
-498.50%-4.38M
-35.86%1.22M
-121.34%-961K
31.75%-763K
-Change in prepaid assets
-143.83%-380K
22.52%370K
-54.56%-881K
32.88%388K
-130.49%-257K
213.48%867K
151.01%302K
40.63%-570K
-29.98%292K
127.22%843K
-Change in payables and accrued expense
-505.05%-7.86M
-18.96%-1.69M
-277.15%-5.49M
-32.82%-951K
-72.67%267K
-17.79%1.94M
-396.15%-1.42M
0.65%3.1M
-325.16%-716K
230.27%977K
-Change in other current assets
150.01%2.46M
128.30%783K
178.67%343K
391.98%1.59M
87.50%-256K
-241.68%-4.93M
-97.36%-2.77M
-205.31%-436K
173.64%324K
-14,528.57%-2.05M
-Change in other current liabilities
179.97%966K
-313.68%-1.45M
326.14%744K
661.79%2.26M
-372.00%-590K
-258.32%-1.21M
-122.51%-351K
-20.96%-329K
-50.94%-403K
51.36%-125K
-Change in other working capital
1.54%-1.53M
-43.15%-209K
64.15%-195K
-30.57%-598K
-29.76%-532K
-142.84%-1.56M
-1,227.27%-146K
-51.53%-544K
12.76%-458K
-109.05%-410K
Cash from discontinued investing activities
Operating cash flow
-10.59%-70.01M
40.43%-11.35M
-14.94%-16.22M
-39.90%-19.98M
-41.67%-22.46M
-45.91%-63.3M
-56.68%-19.06M
-30.13%-14.11M
-68.62%-14.28M
-33.14%-15.85M
Investing cash flow
Cash flow from continuing investing activities
738.15%80.31M
1,292.50%28.13M
154.35%8.14M
6,548.48%36.18M
47.83%7.86M
80.64%-12.58M
96.36%-2.36M
-51,551.72%-14.98M
-3,907.14%-561K
5,815.05%5.32M
Net PPE purchase and sale
-123.30%-2.34M
107.37%58K
64.58%-51K
-176.06%-196K
-4,675.56%-2.15M
-538.41%-1.05M
-2,710.71%-787K
-396.55%-144K
-407.14%-71K
51.61%-45K
Net investment purchase and sale
816.33%82.64M
1,885.81%28.07M
155.22%8.19M
7,522.86%36.37M
86.68%10.01M
82.21%-11.54M
97.58%-1.57M
---14.84M
---490K
--5.36M
Cash from discontinued investing activities
Investing cash flow
738.15%80.31M
1,292.50%28.13M
154.35%8.14M
6,548.48%36.18M
47.83%7.86M
80.64%-12.58M
96.36%-2.36M
-51,551.72%-14.98M
-3,907.14%-561K
5,815.05%5.32M
Financing cash flow
Cash flow from continuing financing activities
-87.01%8.53M
-100.01%-1K
94.50%-23K
-100.19%-89K
216,000.00%8.64M
-31.75%65.69M
18.92M
-77.12%-418K
-51.10%47.19M
-33.33%4K
Net common stock issuance
-87.26%8.82M
-100.01%-1K
--0
----
----
-31.10%69.24M
--19.24M
--0
----
----
Net preferred stock issuance
----
----
----
----
--8.81M
----
----
----
----
--0
Proceeds from stock option exercised by employees
-97.09%3K
--0
--0
--0
-25.00%3K
1,187.50%103K
--0
--2K
--97K
-50.00%4K
Net other financing activities
92.06%-290K
--0
94.52%-23K
---98K
---169K
13.94%-3.65M
---322K
-77.97%-420K
----
----
Cash from discontinued financing activities
Financing cash flow
-87.01%8.53M
-100.01%-1K
94.50%-23K
-100.19%-89K
216,000.00%8.64M
-31.75%65.69M
--18.92M
-77.12%-418K
-51.10%47.19M
-33.33%4K
Net cash flow
Beginning cash position
-30.04%23.75M
-1.71%25.79M
-39.20%33.9M
-24.01%17.79M
-30.04%23.75M
-26.33%33.94M
-76.35%26.24M
-54.33%55.75M
-31.31%23.41M
-26.33%33.94M
Current changes in cash
284.61%18.83M
771.93%16.78M
72.54%-8.11M
-50.20%16.11M
43.46%-5.95M
15.96%-10.2M
96.76%-2.5M
-165.60%-29.51M
-63.25%32.34M
12.18%-10.53M
End cash Position
79.28%42.57M
79.28%42.57M
-1.71%25.79M
-39.20%33.9M
-24.01%17.79M
-30.04%23.75M
-30.04%23.75M
-76.35%26.24M
-54.33%55.75M
-31.31%23.41M
Free cash flow
-12.43%-72.35M
43.09%-11.29M
-14.14%-16.27M
-40.58%-20.18M
-54.79%-24.6M
-47.77%-64.35M
-62.77%-19.85M
-31.11%-14.26M
-69.18%-14.35M
-32.48%-15.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.59%-70.01M40.43%-11.35M-14.94%-16.22M-39.90%-19.98M-41.67%-22.46M-45.91%-63.3M-56.68%-19.06M-30.13%-14.11M-68.62%-14.28M-33.14%-15.85M
Net income from continuing operations -49.07%-93.44M27.56%-10.98M24.14%-11.87M-208.18%-48.13M-38.12%-22.45M-13.39%-62.68M-6.47%-15.16M-5.99%-15.65M-8.72%-15.62M-36.47%-16.26M
Depreciation and amortization 69.42%471K77.65%151K157.35%39K730.43%145K-52.11%136K-73.95%278K-61.71%85K-124.37%-68K-108.04%-23K1.43%284K
Change In working capital -29.91%-6.35M49.87%-2.2M-549.10%-5.48M380.65%2.7M-79.29%-1.37M-207.24%-4.89M-498.50%-4.38M-35.86%1.22M-121.34%-961K31.75%-763K
-Change in prepaid assets -143.83%-380K22.52%370K-54.56%-881K32.88%388K-130.49%-257K213.48%867K151.01%302K40.63%-570K-29.98%292K127.22%843K
-Change in payables and accrued expense -505.05%-7.86M-18.96%-1.69M-277.15%-5.49M-32.82%-951K-72.67%267K-17.79%1.94M-396.15%-1.42M0.65%3.1M-325.16%-716K230.27%977K
-Change in other current assets 150.01%2.46M128.30%783K178.67%343K391.98%1.59M87.50%-256K-241.68%-4.93M-97.36%-2.77M-205.31%-436K173.64%324K-14,528.57%-2.05M
-Change in other current liabilities 179.97%966K-313.68%-1.45M326.14%744K661.79%2.26M-372.00%-590K-258.32%-1.21M-122.51%-351K-20.96%-329K-50.94%-403K51.36%-125K
-Change in other working capital 1.54%-1.53M-43.15%-209K64.15%-195K-30.57%-598K-29.76%-532K-142.84%-1.56M-1,227.27%-146K-51.53%-544K12.76%-458K-109.05%-410K
Cash from discontinued investing activities
Operating cash flow -10.59%-70.01M40.43%-11.35M-14.94%-16.22M-39.90%-19.98M-41.67%-22.46M-45.91%-63.3M-56.68%-19.06M-30.13%-14.11M-68.62%-14.28M-33.14%-15.85M
Investing cash flow
Cash flow from continuing investing activities 738.15%80.31M1,292.50%28.13M154.35%8.14M6,548.48%36.18M47.83%7.86M80.64%-12.58M96.36%-2.36M-51,551.72%-14.98M-3,907.14%-561K5,815.05%5.32M
Net PPE purchase and sale -123.30%-2.34M107.37%58K64.58%-51K-176.06%-196K-4,675.56%-2.15M-538.41%-1.05M-2,710.71%-787K-396.55%-144K-407.14%-71K51.61%-45K
Net investment purchase and sale 816.33%82.64M1,885.81%28.07M155.22%8.19M7,522.86%36.37M86.68%10.01M82.21%-11.54M97.58%-1.57M---14.84M---490K--5.36M
Cash from discontinued investing activities
Investing cash flow 738.15%80.31M1,292.50%28.13M154.35%8.14M6,548.48%36.18M47.83%7.86M80.64%-12.58M96.36%-2.36M-51,551.72%-14.98M-3,907.14%-561K5,815.05%5.32M
Financing cash flow
Cash flow from continuing financing activities -87.01%8.53M-100.01%-1K94.50%-23K-100.19%-89K216,000.00%8.64M-31.75%65.69M18.92M-77.12%-418K-51.10%47.19M-33.33%4K
Net common stock issuance -87.26%8.82M-100.01%-1K--0---------31.10%69.24M--19.24M--0--------
Net preferred stock issuance ------------------8.81M------------------0
Proceeds from stock option exercised by employees -97.09%3K--0--0--0-25.00%3K1,187.50%103K--0--2K--97K-50.00%4K
Net other financing activities 92.06%-290K--094.52%-23K---98K---169K13.94%-3.65M---322K-77.97%-420K--------
Cash from discontinued financing activities
Financing cash flow -87.01%8.53M-100.01%-1K94.50%-23K-100.19%-89K216,000.00%8.64M-31.75%65.69M--18.92M-77.12%-418K-51.10%47.19M-33.33%4K
Net cash flow
Beginning cash position -30.04%23.75M-1.71%25.79M-39.20%33.9M-24.01%17.79M-30.04%23.75M-26.33%33.94M-76.35%26.24M-54.33%55.75M-31.31%23.41M-26.33%33.94M
Current changes in cash 284.61%18.83M771.93%16.78M72.54%-8.11M-50.20%16.11M43.46%-5.95M15.96%-10.2M96.76%-2.5M-165.60%-29.51M-63.25%32.34M12.18%-10.53M
End cash Position 79.28%42.57M79.28%42.57M-1.71%25.79M-39.20%33.9M-24.01%17.79M-30.04%23.75M-30.04%23.75M-76.35%26.24M-54.33%55.75M-31.31%23.41M
Free cash flow -12.43%-72.35M43.09%-11.29M-14.14%-16.27M-40.58%-20.18M-54.79%-24.6M-47.77%-64.35M-62.77%-19.85M-31.11%-14.26M-69.18%-14.35M-32.48%-15.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.